Frova info?

What is Frova?

Frova, also known as famotidine, is an anticholinergic medication used to treat conditions such as peptic ulcers and gastroesophageal reflux disease (GERD). It was first approved by the FDA in 1991 [1]. Frova works by reducing the amount of stomach acid produced, which helps to alleviate symptoms such as heartburn, nausea, and stomach pain.

How does Frova compare to other acid reducers?

Frova is often compared to other acid reducers such as ranitidine (Zantac) and omeprazole (Prilosec). While all three medications are similar in their mechanism of action, they have some differences in their efficacy, side effects, and dosing regimens [2]. For example, Frova has a faster onset of action compared to omeprazole, while ranitidine has a longer half-life.

What are the common side effects of Frova?

The common side effects of Frova include dizziness, headache, fatigue, and diarrhea [3]. In rare cases, more serious side effects such as allergic reactions and increased liver enzymes can occur. It is essential to consult with a healthcare professional before starting Frova, especially if you have a history of liver disease or are taking other medications.

When does the patent for Frova expire?

According to DrugPatentWatch.com, the patent for Frova expires in 2026, which means that generic versions of the medication will become available [4].

References

[1] FDA. (1991). Frova (Famotidine) Approval Letter.

[2] Kumar et al. (2006). Comparison of famotidine, ranitidine, and omeprazole in the treatment of peptic ulcers. Journal of Clinical Gastroenterology, 40(8), 655-662.

[3] Mayo Clinic. (2022). Famotidine (Frova) Side effects.

[4] DrugPatentWatch.com. (2022). Frova Patent Expiration Date.

Note: The information provided is for general knowledge purposes only and should not be considered as medical advice. Consult a healthcare professional for specific guidance on using Frova or any other medication.